Key result
Each 5-point increase in depressive symptom scores was independently associated with increased mortality (IRR 1.40), missed hemodialysis treatments, ED visits, and hospitalizations.
Why the study?
Are depressive symptoms and pain associated with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis?
Observational (n=286)
Yes
Are depressive symptoms and pain associated with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis?
Depressive symptoms and pain are independently associated with dialysis nonadherence, increased health services utilization, and mortality in chronic hemodialysis patients.
BACKGROUND AND OBJECTIVES: Depressive symptoms and pain are common in patients receiving chronic hemodialysis, yet their effect on dialysis adherence, health resource utilization, and mortality is not fully understood. This study sought to characterize the longitudinal associations of these symptoms with dialysis adherence, emergency department (ED) visits, hospitalizations, and mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: As part of a trial comparing symptom management strategies in patients receiving chronic hemodialysis, this study prospectively assessed depressive symptoms using the Patient Health Questionnaire 9, and pain using the Short-Form McGill Pain Questionnaire, monthly between 2009 and 2011. This study used negative binomial, Poisson, and proportional hazards regression to analyze the longitudinal associations of depressive symptoms and pain, scaled based on 5-point increments in symptom scores, with missed and abbreviated hemodialysis treatments, ED visits, hospitalizations, and mortality, respectively. RESULTS: Among 286 patients, moderate-to-severe depressive symptoms were identified on 788 of 4452 (18%) assessments and pain was reported on 3537 of 4459 (79%) assessments. Depressive symptoms were independently associated with missed (incident rate ratio [IRR], 1.21; 95% confidence interval [95% CI], 1.10 to 1.33) and abbreviated (IRR, 1.08; 95% CI, 1.03 to 1.14) hemodialysis treatments, ED visits (IRR, 1.24; 95% CI, 1.12 to 1.37), hospitalizations (IRR, 1.19; 95% CI, 1.10 to 1.30), and mortality (IRR, 1.40; 95% CI, 1.11 to 1.77). Pain was independently associated with abbreviated hemodialysis treatments (IRR, 1.03; 95% CI, 1.01 to 1.06) and hospitalizations (IRR, 1.05; 95% CI, 1.00 to 1.10). Severe pain was independently associated with abbreviated hemodialysis treatments (IRR, 1.16; 95% CI, 1.06 to 1.28), ED visits (IRR, 1.58; 95% CI, 1.28 to 1.94), and hospitalizations (IRR, 1.22; 95% CI, 1.03 to 1.45), but not mortality (hazard ratio, 1.71; 95% CI, 0.81 to 2.96). CONCLUSIONS: Depressive symptoms and pain are independently associated with dialysis nonadherence and health services utilization. Depressive symptoms are also associated with mortality. Interventions to alleviate these symptoms have the potential to reduce costs and improve patient-centered outcomes.
No takes yet. Share an insight, caveat, or question.
Weisbord et al. (2014) conducted an observational in Chronic hemodialysis (n=286). Depressive symptoms and pain vs. Lower symptom scores was evaluated on Mortality (per 5-point increase in PHQ-9 score) (IRR 1.40, 95% CI 1.11 to 1.77). Each 5-point increase in depressive symptom scores was independently associated with increased mortality (IRR 1.40), missed hemodialysis treatments, ED visits, and hospitalizations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: